Additive effect of melatonin to estradiol upon visceral fat mass in ovariectomized rats

Acta Endocrinologica

Volumn 6, Issue 3, 2010, Pages 315-326

  Ciortea, R ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Estrogens; Melatonin; Metabolic effects; Rats

Indexed keywords

EID: 79960451421     PISSN: 18410987     EISSN: None     Source Type: Journal    
DOI: 10.4183/aeb.2010.315     Document Type: Article

References (32)

1. A.S. Greenberg, M.S. Obin. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutrition 2006; 2:112-116.
2. D. Mihu, N. Costin, R. Ciortea, Carmen Georgescu, Viorela Mihaela Ciortea, Daria Maria Groza. Melatonin, a prognostic marker in oncologic pathology. Gineco. ro 2009; 5(1):48-52.
3. Karasek M., Kowalski A.J., Zylinska K. Serum melatonin circadian profile in women suffering from the genital tract cancers. Neuro Endocrinol Lett 2000; 21(2):109-113.
4. Grin W., Grünberger W.A. Significant correlation between melatonin deficiency and endometrial cancer. Gynecol Obstet Invest 1998; 45(1):62-65.
5. R. Ciortea, N. Costin, D.M. Groza, R. Mocan, S. Susman, C. Bondor, C.M. Mihu, D. Mihu. Melatonin effects in castrated female rats upon endometrial prolifferation (in Romanian). Gineco. ro 2010; 6(19):47-55.
6. Reiter R.J., Calvo J.R., Karbownik M., Qi W., Tan D.X. Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci 2000; 917:376-386.
7. Venkataramanujan S., Warren D., Seithikurippu R., Pandi P., Trakht I., Cardinali D.P. Therapeutic Actions of Melatonin in Cancer: Possible Mechanisms Integrative Cancer Therapies 2008; 7(3):189-903.
8. Dai M., Cui P., Yu M., Han J., Li H, Xiu R. Melatonin modulates the expression of VEGF and HIF-1 alpha induced by CoCl2 in cultured cancer cells. J Pineal Res 2008; 44(2):121-126.
9. Kanishi Y., Kobayashi Y., Noda S., Ishizuka B., Saito K. Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines. J Pineal Res 2000; 28(4):227-233.
10. Cos S., Mediavilla M.D., Fernández R., González-Lamuño D., Sánchez-Barcheló E.: Does melatonin induce apoptosis inMCF-7 human breast cancer cells in vitro? J Pineal Res 2002; 32:90-96.
11. Emilio J Sanchez-Barcelo, Samuel Cos, Dolores Mediavilla, Carlos Martinez-Campa, Alicia Gonzalez, Carolina Alonso-Gonzalez. Melatonin-estrogen interactions in breast cancer. J Pineal Res 2005; 38:217-222.
12. Kanishi Y., Kobayashi Y., Noda S., Ishizuka B., Saito K. Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines. J Pineal Res 2000; 28(4):227-233.
13. Gerdin M.J., Masana M.I., Dubocovich M.L. Melatonin-mediated regulation of human MT(1) melatonin receptors expressed in mammalian cells. Biochem Pharmacol 2004; 67(11):2023-2030.
14. Wolden-Hanson T, Mitton DR, McCants RL, Yellon SM, Wilkinson CW, Matsumoto AM, Rasmussen DD. Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 2000; 141(2):487-497.
15. Rasmussen DD, Boldt BM, Wilkinson CW, Yellon SM, Matsumoto AM. Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology 1999; 140(2):1009-1012.
16. Levine JA, Eberhardt NL, Jensen MD. Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science 1999 8; 283(5399):212.
17. Hall ES, Lynch GR. Two daily melatonin injections differentially induce nonshivering thermogenesis and gonadal regression in the mouse (Peromyscus leucopus). Life Sci 1985; 26 37(8):783-788.
18. Depres-Brummer P, Metzger G, Levi F. Pharmacologic restoration of suppressed temperature rhythms in rats by melatonin, melatonin receptor agonist, S20242, or 8-OH-DPAT. Eur J Pharmacol 1988; 347:57-66.
19. Koster-van Hoffen GC, Mirmiran M, Bos NP, Witting W, Delagrange P, Guardiola-Lemaitre B. Effects of a novel melatonin analog on circadian rhythms of body temperature and activity in young, middle-aged, and old rats. Neurobiol Aging 1993; 14:565-569.
20. Speake BK, Parkin SM, Robinson DS Degradation of lipoprotein lipase in rat adipose tissue. Biochim Biophys Acta 1985; 840:419-422.
21. Kahn HS. The accumulation of visceral adipose tissue may be influenced by intra-abdominal temperature. Obes Res 1996; 4:297-299.
22. Despres JP, Tremblay A, Nadeau A, Bouchard C. Physical training and changes in regional adipose tissue distribution. Acta Med Scand 1988; [Suppl] 723:205-212.
23. Hunter GR, Kekes-Szabo T, Snyder SW, Nicholson C, Nyikos I, Berland L 1997. Fat distribution, physical activity, and cardiovascular risk factors. Med Sci Sports Exercise 29:362-369.
24. Barzilai N, Wang J, Massilon D, Vuguin P, Hawkins M, Rossetti L Leptin selectively decreases visceral adiposity and enhances insulin action. J Clin Invest 1997; 100:3105-3110.
25. Shima T, Chun SJ, Niijima A, Bizot-Espiard JG, Guardiola-Lemaitre B, Hosokawa M, Nagai K. Melatonin suppresses hyperglycemia caused by intracerebroventricular injection of 2-deoxy-Dglucose in rats. Neurosci Lett 1997; 226:119-122.
26. Bartness TJ, Goldman BD. Effects of melatonin on long-day responses in short-day housed adult Siberian hamsters. Am J Physiol 1988; 255(5 Pt 2):R823-830.
27. Bartness TJ, Demas GE, Song CK. Seasonal changes in adiposity: the roles of the photoperiod, melatonin and other hormones, and sympathetic nervous system. Exp Biol Med (Maywood) 2002; 227(6):363-376.
28. Barzilai N, Banerjee S, Hawkins M, Chen W, Rossetti L. Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J Clin Invest 1998 1; 101(7):1353-1361.
29. Hussein MR, Ahmed OG, Hassan AF, Ahmed MA. Intake of melatonin is associated with amelioration of physiological changes, both metabolic and morphological pathologies associated with obesity: an animal model. Int J Exp Pathol 2007; 88(1):19-29.
30. Anwar MM, Meki AR Oxidative stress in streptozotocin-induced diabetic rats: effects of garlic oil and melatonin. Comp Biochem Physiol A Mol Integr Physiol 2003; 135(4):539-547.
31. Müller-Wieland D, Behnke B, Koopmann K, Krone W Melatonin inhibits LDL receptor activity and cholesterol synthesis in freshly isolated human mononuclear leukocytes. Biochem Biophys Res Commun 1994; 30; 203(1):416-421.
32. Dauchy RT, Blask DE, Sauer LA, Davidson LK, Krause JA, Smith LC, Dauchy EM. Physiologic melatonin concentration, omega-3 fatty acids, and conjugated linoleic acid inhibit fatty acid transport in rodent hind limb skeletal muscle in vivo. Comp Med 2003; 53(2):186-190.